1. Developed by Kathy Wonderly RN, BSPA,CPHQ Performance Improvement Coordinator Developed: October 2009 Most recently updated: September 2013

2.  To recognize the importance of the timing of pre- operative prophylactic antibiotic administration.  To identify the need to discontinue the antibiotics within 24 hours of end of surgery. (48 for cardiac surgery)  To demonstrate understanding of the need to remove Foley catheters by post-op day 2.  To identify the risks of hypothermia during surgery.  To identify the increased risks for CABG patients who have hyperglycemia postoperatively.

3.  The SCIP measures have been developed to reduce surgical complications.  They focus on two areas, preventing surgical site infections and reducing the chance of developing either a deep vein thrombosis (DVT) or a pulmonary embolism (PE) along with 1 cardiac measure.  Note: changes for January through September 2014.

4. This is a very general list. The procedures are identified by specific ICD-9-CM code. Cardiac surgery including CABG Hip arthroplasty procedures Knee arthroplasty Colon surgery Hysterectomy Vascular surgery Other major surgeries that include brain procedures, lung procedures, laparoscopic assisted approaches or totally laparoscopic procedures for any of the above categories

5.  In this section there are 7 measures. The first three deal with prophylactic use of antibiotics. It is the surgeons responsibility to order the appropriate antibiotic. Anesthesia, Nursing, and Pharmacy must be sure the time for start and discontinuation are correct.

6.  This measure requires that the prophylactic antibiotic be received within one hour prior to surgical incision.  This is measured by checking the earliest documented start time for the ordered antibiotic and comparing it to the Surgical incision date and time for the procedure. To meet the measure the time cannot exceed 60 minutes. SCIP Preventing Surgical Infections

7. Prophylactic Antibiotic within 1 Hour of Surgical Incision  There are two exception to this rule.  Vancomycin or a fluoroquinolone may be started 2 hours prior to surgery as many patients experience side effects it the medication is administered too fast.  The approved prep for colon surgery includes some oral antibiotics which are taken the evening before surgery.

8. This measure requires the surgeon to order an acceptable antibiotic for the procedure he/she is doing. In general, the approved antibiotics are cephalosporins with vancomycin if the patient is allergic to the cephalosporins. The oral prep for colon surgery is neomycin or erythromycin + metronidazole (Flagyl) There are some cases in which clindamycin can be used for patients with allergies to cephalosporins. The quinolones such as Cipro are also used for specific procedures. (See the following slides for antibiotic recommendations)

9. Prophylactic Antibiotic Regimen Selection for Surgical Procedure PROCEDURE CATEGORY APPROVED ANTIBIOTICS CABG, Other Cardiac or Vascular Cefazolin, Cefuroxime OR Vancomycin** * If β-lactam allergy: Vancomycin OR Clindamycin

10. Prophylactic Antibiotic Regimen Selection for Surgical Procedure Procedure Category Approved antibiotics Hip/Knee Arthroplasty Cefazolin or Cefuroxime OR Vancomycin ** If β-lactam allergy: Vancomycin OR Clindamycin

11. Prophylactic Antibiotic Regimen Selection for Surgical Procedure Procedure category Approved antibiotics Colon Cefotetan, Cefoxitin, Ampicillin/Sulbactam, or Ertapenem † A single dose of ertapenem (Invanz) is recommended for colon procedures. OR Cefazolin or Cefuroxime + Metronidazole If β-lactam allergy: Clindamycin + Aminoglycoside OR Ceftriazone + Metronidazole ( for hospitals having SSI ca SSI’s caused by gram – organisms resistant to 1 st or 2 nd generation clep cephalosporins. OR Clindamycin + Quinolone, or Clindamycin + Aztreonam OR Metronidazole + Aminoglycoside OR Metronidazole + Quinolone

12. Prophylactic Antibiotic Regimen Selection for Surgical Procedure Procedure category Approved antibiotic Hysterectomy Cefotetan, Cefazolin, Cefoxitin, Cefuroxime, OR Ampicillin/Sulbactam If β-lactam allergy: Clindamycin + Aminoglycoside Or Clindamycin + Quinolone or Clindamycin + Aztreonam OR Metronidazole + Aminoglycoside or OR Metronidazole + Quinolone OR Vancomycin + Aminoglycoside or Vancomycin + Azetreonam or Vancomycin + Quinolone

13. Approved antibiotics: Cefotetan, Cefazolin, Cefoxitin, Cefuroxime, OR Ampicillin/Sulbactam OR Ertapenem If β-lactam allergy: Clindamycin + Aminoglycoside OR Clindamycin + Quinolone OR Clindamycin + Aztreonam OR Metronidazole + Aminoglycoside OR Metronidazole + Quinolone

14. Special Considerations *For cardiac, orthopedic, and vascular surgery, if the patient is allergic to β-lactam antibiotics, Vancomycin or Clindamycin are acceptable substitutes. **Vancomycin is acceptable with a physician/APN/PA/ pharmacist documented justification for its use Reference: Specifications Manual for National Hospital Inpatient Quality Measures Discharges 01-01-14 (1Q14) through 9-30-14(3Q14)

15.  Patients who had other procedures requiring general or spinal anesthesia that occurred within 3 days ( 4 days for cardiac surgery) prior to or after the procedure (during a separate surgical episode but during the same hospital stay) are excluded from the appropriate antibiotic prophylaxis measure.  Patients who were receiving antibiotics more than 24 hours before surgery.

16. Research shows that the success of the prophylactic antibiotics lies with maintaining a drug blood level during surgery. If the procedure is long (over 4 hours) a second dose may need to be given.

17. The prophylactic antibiotic must be discontinued within 24 hours after Anesthesia end time. The 24 hour clock starts from the anesthesia end time recorded in the medical record. If your facility uses standardized medication administration times you will have to be sure that the antibiotics that are ordered q6 x 4 doses or q8 hours x 3 doses do not exceed the 24 hour limit.

18.  There is no evidence that administering antibiotics for more that a few hours after the incision is closed offers additional benefit. Based on this many surgeons are not ordering any prophylactic antibiotics post –op or order just one dose to be given before the patient leaves PACU.

19.  There is one exception to this indicator.  The antibiotics need to be discontinued within 48 hours for cardiac surgery.

20.  There are some approved reasons for extending the antibiotics beyond the 24 hour (48hr for cardiac surgery) timeframe.  These are: 1. Erythromycin administered for the purpose of increasing gastric mobility 2. For treating hepatic encephalopathy 3. Prophylaxis for Pneumocystis pneumonia (PCP) 4. If the patient has an infection 5. If the patient has a current malignancy of the lower extremity involving the same extremity as the joint revision surgery. 6. If a culture of the operative site is taken after incision but prior to the administration of prophylactic antibiotic for a joint revision surgery.

21.  The practitioner must document the very specific reason for the antibiotic extension. This must be either written or dictated after the incision but within 2 days (3 days for cardiac surgery) after the anesthesia end time.

22.  This measure is for cardiac surgery only. It requires that the patient has a controlled (<180 mg/dL) blood glucose at 18 to 42 hours after anesthesia end time.

23.  Evidence based medicine has shown that both diabetic and non-diabetic patients who have hyperglycemia in the immediate post-op phase have an increased chance of developing a deep wound infection or acute renal failure, requiring additional blood transfusions and post-operative mortality.

24. This measure is no longer required by CMS but remains a Joint Commission measure. driven. Surgery patients should have appropriate hair removal. This includes no hair removal or the use of clippers or depilatory. The key to meeting this measure is clear documentation which must include the device used. Many times the word “shaved” is used meaning with clippers and is interpreted as using a razor.

25.  This measure requires that the patient have their urinary catheter removed by post-op day two.  Exceptions to this measure are patients who had urological, gynecological or perineal procedures performed or patients who had a urinary diversion or urethral catheter in place or were being intermittently catheterized preoperatively or prior to hospital arrival.

26. This measure is related to the well established infection control data that shows the risk of catheter related urinary tract infection (UTI) is directly related to the length of time a catheter remains in place.

27. Some studies show that 24% of patients will develop a symptomatic UTI and 3.6% will develop bacteremia when a catheter remains in place from 2-10 days. Other studies demonstrated that surgical patients who have a urinary catheter in place for more than 2 days were twice as likely to develop a UTI prior to discharge.

28. A 2006 study reports that in Orthopedic patients it was found that limiting the use and duration of indwelling catheters resulted in a 60% reduction in UTI’s.

29.  This measure is both practitioner and nursing driven and requires clear documentation.  The date and time the catheter is removed must be documented.  If the catheter is not removed, at the time of the decision(before the end of p.o. day 2) the practitioner must document the specific reason for continued urinary catheterization.

30. Any time there is duplicate documentation in the medical record there is a risk for error and duplication wastes time for many care providers. It is important that the team members coordinate their documentation so that there are not multiple times for the same intervention. CMS has a standing rule that the chart abstractor must use the earliest time for the start measures and the latest documented time for the stop measures.

31.  Hypothermia has always been a concern for patients undergoing general surgery.  Research shows that there is an increased risk for impaired wound healing, adverse cardiac events as well as altered drug metabolism and coagulation responses.  These complications have led to unanticipated admissions to ICU, mechanical ventilation and the increased need for blood product administration.

32.  Nursing can take the lead with this measure by being sure that their patients undergoing general anesthesia lasting more than 60 minutes have active warming (forced air warming or warm water garment) during the procedure to maintain a body temperature of greater than 96.8F/36C.  If some procedures hypothermia is intentially maintained. In these cases intentional hypothermia must be documented in the medical record.

33.  The perioperative time is from 30 minutes immediately prior to or 15 minutes immediately following the anesthesia end time.  Is not only necessary to monitor the patient’s temperature during the perioperative period. It is also necessary to document the date, time and the temperature in the medical record

34. The SCIP measures are complicated and require good team work and communication between care givers. Many facilities and surgeons have pre- established orders for all of their patients that include the SCIP measures we reviewed in this session.

35. 1.Any antibiotic is acceptable to be used for surgical prophylaxis. A. True B. False

36. 2. The 24 hour clock for discontinuing prophylactic antibiotics starts with the__________________ end time. A. Incision B. Anesthesia C. Room charge

37. 3. Hyperglycemia has been associated with increasing the risk of ________________ for patients undergoing CABG surgery. A.infection B.mortality C.acute renal failure D.increased blood transfusions E. all of the above

38. 4. To reduce the risk of developing a post surgical urinary track infection, the urinary catheter should be removed before or on post-op day two even if the patient had it in use before the perioperative period. A. True B. False

39. 5. Hypothermia during surgery can lead to an increased risk for ____________________. A. Impaired wound healing B. Adverse cardiac events C. Seizures D. A & B

40. SCIP Part II is on the PowerPoint presentation SCIP-VTE